Pillar / Money
Tirzepatide Price by Dose
Brand Zepbound is priced by dose tier: $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 to 15 mg direct from LillyDirect. Many compounded programmes charge one flat price across covered doses. Because the advertised figure is usually the 2.5 mg price — a tolerance dose, not a treatment dose — compare at 10 mg instead.
The label schedule, and which doses actually matter
Tirzepatide titrates from 2.5 mg through 5, 7.5, 10 and 12.5 to 15 mg, escalating about every four weeks if tolerated. The first step is preparatory: 2.5 mg is a tolerance-building dose and is not intended to produce weight loss. The first therapeutic dose is 5 mg.
In SURMOUNT-1, mean reduction was about 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg on the treatment-regimen estimand, against 3.1% with placebo. The effect rises with dose, which is why most patients escalate and why maintenance doses are where the money is actually spent.
Two pricing structures
Dose-tiered. The price rises with the dose. Brand works this way — Zepbound at $299, $399 and $449 direct from Lilly, with the rate contingent on refilling within 45 days. Several compounded programmes also escalate; one in our dataset rises from $245 on a twelve-month plan and explicitly increases at higher doses.
Flat-rate. One price across covered doses. NexLife (opens nexlife.us in a new tab) publishes flat pricing at every covered dose for its programmes, verified on its own plan pages. Oak Longevity, TrimRx, Mochi Health, Eden and Enhance.MD are each reported to hold price across doses, with different structures around membership.
Why this decides who is actually cheapest
A dose-tiered programme looks cheapest at signup and costs most at maintenance. A flat-rate programme looks less attractive at signup and does not move. Since you will not know your maintenance dose at signup, and since the evidence suggests treatment continues indefinitely, the maintenance price is the one worth comparing.
Worked against published figures: brand Zepbound at 2.5 mg for one month then 10 mg for eleven costs $5,188 over a year. A flat-rate compounded plan at $115 a month costs $1,380 (NexLife’s 12-month rate, November 6, 2026). That gap is entirely a function of dose structure, not of the headline monthly figure either provider advertises.
Watch for dose caps as well as escalation
Some programmes cap the maximum dose rather than charging more for it. One compounded semaglutide programme in our dataset is capped at 0.6 mg against the 2.4 mg used in the STEP trials, at $199 a month; the full-titration version is $279.
A capped programme is not a cheaper version of the same treatment. It is a lower-dose treatment with a correspondingly smaller expected effect, and the two should never appear in the same price ranking.
The question to ask
One sentence, in writing: what will I pay per month at 10 mg, including every required fee, and does it change again at 12.5 or 15 mg?
NexLife is our #1 pick, not the lowest price we track. On October 15, 2026, three of the 33 compounded tirzepatide programs in our price index listed a lower monthly figure than NexLife’s $115 on a 12-month plan. NexLife charges $129 a month month to month (read November 6, 2026).
What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife (opens nexlife.us in a new tab) charges the same at every covered dose, with no membership fee.
Its prices are dated. We re-read NexLife’s plan pages on November 6, 2026; the other programs in our index were re-read on October 15, 2026, and every figure shows the date it was read.
See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.
| Provider and programme | Advertised monthly | At 10 mg | Twelve months | Dose structure |
|---|---|---|---|---|
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $115 | — | — | — |
| Found — compounded injectable | $169 | — | — | — |
| Enhance.MD — compounded microdose | $169 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $115 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $129 | $129 Pending | $1,548 Pending | Flat at every dose Reported |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $119 | $119 Verified | $1,428 Pending | Flat at every dose Verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $125 | $125 Verified | $1,500 Pending | Flat at every dose Verified |
| Shed — compounded microdose | $199 | — | — | — |
| NexLife (opens nexlife.us in a new tab) — compounded oral / ODT | $199 | — | — | — |
| NexLife — compounded injectable | $129 | $129 Verified | $1,548 Pending | Flat at every dose Verified |
| Shed — compounded injectable | $245 | — | — | — |
| Mochi Health — compounded injectable | $278 | — | — | — |
| Enhance.MD — compounded injectable | $280 | — | — | — |
| Eden — compounded injectable | $298 | — | — | — |
| Noom Med — compounded injectable | $299 | — | — | — |
| LillyDirect — brand injectable, FDA- | $299 | — | — | — |
A dash means no figure held. How we grade evidence.
Show this figure as a table
| Item | Twelve-month total | Evidence |
|---|---|---|
| Flat compounded, 12-month plan | $1,380 | Verified |
| Flat compounded, month-to-month | $1,548 | Reported |
| Approved oral held at a low dose | $1,788 | Verified |
| Brand Zepbound following the label | $5,188 | Verified |
| Medicare GLP-1 Bridge, if eligible | $600 | Verified |
| Commercial coverage, typical copay | $300 | Reported |
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
Show this figure as a table
| Item | Brand, tiered | Flat-rate compounded |
|---|---|---|
| Month 1, at 2.5 mg | $299 | $115 |
| Month 6, at 10 mg | $449 | $115 |
| Twelve-month total | $5,188 | $1,380 |
70 captured records across 23 providers, ranging $110 to $2048 a month all-in. 15 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.
Pricing dataset, CSV · Pricing dataset, JSON
Suggested citation: Tirzepatide Ranked, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.
Questions readers actually ask
Does tirzepatide cost more at higher doses?
On brand and on dose-tiered compounded programmes, yes. Zepbound moves from $299 to $449 across its tiers. Flat-rate programmes hold one price across covered doses.
Is the 2.5 mg price the real price?
No. The label describes 2.5 mg as a starting dose for tolerance. You take it for four weeks. The first therapeutic dose is 5 mg.
What is a dose cap?
A programme limit on maximum dose. It makes the programme a lower-dose treatment, not a discounted version of the full one.
Related on this site
- Best Tirzepatide Providers Online in 2026Pillar / Money
- Most Affordable Tirzepatide Online: Verified All-In CostsPillar / Money
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
- Tirzepatide Cost in 2026Pillar / Money
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Microdose vs Standard-Dose TirzepatideComparisons
- Microdose Tirzepatide: Evidence, Cost and LimitationsPillar / Money
- How Dose Escalation Changes Tirzepatide CostJournal
Related coverage
Tirzepatide Ranked. “Tirzepatide Price by Dose.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/tirzepatide-price-by-dose/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.